Leeza Osipenko

How aligned are the perspectives of EU regulators and HTA bodies? A comparative analysis of regulatory‐HTA parallel scientific advice

Giovanni Tafuri, Margherita Pagnini, Jane Moseley et al. · British Journal of Clinical Pharmacology · 2016 · 63 citations · Full text

Costs and Causes of Oncology Drug Attrition With the Example of Insulin-Like Growth Factor-1 Receptor Inhibitors

Valerie Jentzsch, Leeza Osipenko, Jack W. Scannell et al. · JAMA Network Open · 2023 · 44 citations · Full text

The impact of parallel regulatory–health technology assessment scientific advice on clinical development. Assessing the uptake of regulatory and health technology assessment recommendations

Giovanni Tafuri, Inês Lucas, Steve Estevão et al. · British Journal of Clinical Pharmacology · 2018 · 37 citations · Full text

NICE's evaluations of medicines authorized by EMA with conditional marketing authorization or under exceptional circumstances

Pilar Pinilla‐Dominguez, Huseyin Naci, Leeza Osipenko et al. · International Journal of Technology Assessment in Health Care · 2020 · 16 citations

Audit of data redaction practices in NICE technology appraisals from 1999 to 2019

Leeza Osipenko · BMJ Open · 2021 · 15 citations · Full text